Transform Your Thoughts into Impactful Words: Make a Difference through the Power of Blogging!

Global Plasma Fractionation Market Size, Share, Price, Report and Forecast 2023-2028

Plasma Fractionation Market

The ‘Global Plasma Fractionation Market Share, Size, Price, Trends, Growth, Report and Forecast 2023-2028’ by Expert Market Research gives an extensive outlook of the global plasma fractionation market, assessing the market on the basis of its segments like product, application, processing technology, end use, and major regions.

The report studies the latest updates in the market, along with their impact across the market. It also analyses the market demand, together with its price and demand indicators. The report also tracks the market on the bases of SWOT and Porter’s Five Forces Models.

Plasma Fractionation Market Share, Price, Trends, Growth, Key Players, Report and Forecast

The key highlights of the report include:

Market Overview (2018-2028)

• Forecast CAGR (2023-2028): 6.70%

The major factors driving the growth of the global plasma fractionation market include the surging demand for plasma-derived medicinal products and the increasing use of immunoglobulins. The increasing geriatric population and rising prevalence of communicable diseases and infections like influenza and HIV is likely to further drive the growth of this market. The rising number of plasma collection centres and the surging use of alpha-1-antitrypsin is further increasing the demand for plasma fractionation. Furthermore, the rising incidences of accidents, allergies and infections is adding to the market growth.

Get a Free Sample Report with Table of Contents –

Immunoglobulins products of the plasma fractionation market are expected to register a steady growth owing to the rising prevalence of neurological disorders and growing usage of subcutaneous Immunoglobulin (SCIg) therapy due to reduced administration time. The neurology applications of plasma fractionation are likely to witness growth in the forecast period in line with the extensive use of plasma proteins in various neurological diseases treatments. Meanwhile, hematology applications are also likely to flourish in the future due to rapid advancements in hemostasis technologies. Hospitals and clinics are a significant end user and are projected to expand in the forecast period due to the surging demand for plasma-based products and greater adoption of plasma-therapies in private hospitals and clinics.

Plasma Fractionation Industry Definition and Major Segments

Plasma fractionation is the process of separating the various protein constituents of plasma that has been harvested from donors. Plasma is the basis for treatment of various chronic diseases since it carries essential proteins, hormones, and nutrients throughout the body. The fibrinogen, albumin, and antibodies of plasma can be separated to treat burns, trauma, shock, and rare chronic diseases.

Read Full Report with Table of Contents –

On the basis of product, the market is segmented into:

• Immunoglobulins
• Coagulation Factor Concentrates
• Albumin
• Protease Inhibitors
• Others

Based on application, the market is classified into:

• Neurology
• Immunology
• Hematology
• Rheumatology
• Others

On the basis of processing technology, the market is divided into:

• Ion- Exchange Chromatography
• Affinity Chromatography
• Cryopreservation
• Ultrafiltration
• Microfiltration

Based on end use, the market is categorised into:

• Hospitals and Clinics
• Clinical Research Laboratories
• Academic Institutes
• Others

On the basis of region, the market is segmented into:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Plasma Fractionation Market Trends

The surging demand for plasma fractionation products for manufacturing vaccines and biopharmaceuticals is likely to impact the growth of the plasma fractionation market positively. The key trends propelling the growth of this market include the rising prevalence of bleeding and respiratory disorders and the deployment of technologically advanced plasma fractionation techniques. The growing research and development activities for plasma-based products and the rising awareness programmes encouraging blood donation is fostering the growth of the market for plasma fractionation. The adoption of more sophisticated chromatographic techniques and genetic engineering is likely to minimise contamination by viruses and ensure higher purity, thus bolstering the market.

The emergence of intravenous immunoglobulin (IVIG) in the treatment of idiopathic, autoimmune, and infectious diseases is accelerating the growth of the plasma fractionation market. The rising prevalence of blood-related disorders and genetic disorders like Alpha-1 antitrypsin deficiency (AATD) are generating lucrative opportunities for the growth of this market. The increased regulations of various governments and the development of novel therapeutic products in order to treat abnormalities in plasma protein levels is augmenting the market growth. Furthermore, the establishment of good laboratory practices (GLP) and the increased focus of market players on developing technologically advanced plasma fractionation plants are likely to expand the plasma fractionation market further.

Key Market Players

The major players in the global plasma fractionation market report are:

• CSL Plasma LLC
• Grifols, S.A.
• Takeda Pharmaceutical Company Limited
• Biotest Group
• Baxter International Inc.
• Others

The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.

Related Reports:

Battery Recycling Market:

Solid Oxide Fuel Cell Market:

Waste Management Market:

Epigenetics Market:

About Us:

Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skilful analysis and interpretation of data, the company offers its clients extensive, latest and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.

EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.

Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.

Media Contact:

Company Name: Claight Corporation
Contact Person: Anisha Luccas, Business Consultant
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA

Related Posts